Rebecca Chen
Papers
2
Total Citations
32
H-Index
2
About
Dr. Rebecca Chen is a clinical molecular geneticist whose work bridges infectious disease genomics and population genetics. She is best known for developing a high-throughput SARS-CoV-2 whole genome sequencing workflow for clinical laboratories, a critical tool for tracking viral mutations that inform diagnostic and therapeutic strategies during the COVID-19 pandemic. Her 2022 paper on this method has garnered 26 citations, underscoring its practical impact on public health surveillance. Earlier in her career, Dr. Chen contributed to precision medicine by designing a rapid one-step carrier detection assay for Mucolipidosis IV mutations in the Ashkenazi Jewish population, a targeted screening approach that enhances reproductive risk assessment. Her research demonstrates a commitment to translating genomic technologies into actionable clinical tools, from pandemic response to rare disease prevention. By enabling real-time monitoring of viral evolution and streamlining carrier testing for inherited disorders, Dr. Chen’s work exemplifies how molecular diagnostics can directly improve patient care and population health outcomes.
Research Focus
Key Achievements
Top Papers
- 1
- 2